Johnson & Johnson CEO Discusses Q4 2013 Results - Earnings Call Transcript
Johnson & Johnson ( JNJ ) Q4 2013 Results Earnings Call January 21, 2014 8:30 AM ET
Good morning, and welcome. I’m Louise Mehrotra, Vice President of Investor Relations for Johnson & Johnson, and it is my pleasure this morning to review our business results for the fourth quarter and full year of 2013.
Joining me on the podium today are Alex Gorsky, Chairman of the Board and Chief Executive Officer, and Dominic Caruso, Vice President, Finance and Chief Financial Officer. A few logistics before we get into the details.
This review is being made available to a broader audience via a webcast accessible through the Investor Relations section of the Johnson & Johnson website. I’ll begin by briefly reviewing highlights of the fourth quarter and full year of 2013 for the corporation and highlights for our three business segments.
Following my remarks, Alex will comment on the 2013 results and provide a strategic outlook for the company. Dominic will then provide some additional commentary on financial results and guidance for 2014. We will then open the meeting to your questions. We expect the meeting to conclude at approximately 10:15.
- "They both have a temper, and in a strange way, ortho - because it's very physical and you're breaking bones - helps vent that for both of them." Am I the only one that feels sorry for their patients? Page 3 of 4 - Do you have any Orphan Black scoop on